Casellas-Pujol, E, Soler, J, Schmidt, C, Soriano, J, Pascual, JC. Long-lasting symptoms in borderline personality disorder: Defining an emergent population with differential clinical and therapeutic features. Personality and Mental Health. 2024; 18(3)DOI:10.1002/pmh.1614. PMID:38666509. IF:2.700(Q2/4D).

Santero, M, Requeijo, C, Quintana, MJ, Rodríguez, D, Bottaro, D, Macias, I, Pericay, C, Farina, N, Blanco, JM, Urreta-Barallobre, I, Punti, L, Nava, MA, Cosp, XB. How appropriate is treating patients diagnosed with advanced esophageal cancer with anticancer drugs? A multicenter retrospective cohort Spanish study. Clinical & Translational Oncology. 2024; 26(10)DOI:10.1007/s12094-024-03436-1. PMID:38662169. IF:2.500(Q3/6D).

Pieren, M, Gutiérrez-Solana, AA, Arbós, RMA, Boyle, GW, Davila, M, Davy, M, Gitzinger, M, Husband, L, Martínez-Martínez, MS, Mazarro, DO, Pefani, E, Penman, SL, Remuiñán, MJ, Vlasakakis, G, Zeitlinger, M, Dale, GE. First-in-human study of alpibectir (BVL-GSK098), a novel potent anti-TB drug. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2024; 79(6)DOI:10.1093/jac/dkae107. PMID:38656557. IF:3.600(Q2/3D).

Schwartzman, S, Puig, L, Cohen, AD, Khattri, S, Jossart, C, Diaz, C, Garrelts, A, Zhu, DT, Eberhart, N, Eleftheriadi, A, Tangsirisap, N, Schuster, C, Gottlieb, AB, Sheesh, M. An integrated safety analysis of treatment-emergent fungal infections in patients with psoriasis, psoriatic arthritis, or axial spondyloarthritis treated with ixekizumab from 26 clinical studies. RHEUMATOLOGY. 2024; 63DOI:10.1093/rheumatology/keae163.211. PMID:. IF:4.400(Q1/1D).